First human tests begin for new drug formulation
NCT ID NCT07421778
Summary
This is an early-stage study to check the safety and how the body processes a new version of an experimental drug called QRL-101. It will involve 48 healthy volunteers who will receive either the drug or a placebo. The main goal is to see if the drug is safe and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
ICON plc.
RECRUITINGGroningen, 9728 NZ, Netherlands
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.